Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Public health decisions should rely on independent trials, not biased literature.

Ritlecitinib shows promise in improving severe alopecia areata, with 27% of patients seeing success.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

MK-5108 is safe and shows potential against tumors, especially alone.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

CTP-543 is generally safe for treating alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

Baricitinib is effective and safe for treating severe alopecia areata.